48,830
edits
m (→Drug-induced liver disease: +SO example) |
m (→Sign out) |
||
Line 587: | Line 587: | ||
The findings are compatible with nonalcoholic steatohepatitis (NASH), alcoholic | The findings are compatible with nonalcoholic steatohepatitis (NASH), alcoholic | ||
steatohepatitis (ASH) or drug effect. The steatosis is periportal predominant; this | steatohepatitis (ASH) or drug effect. The steatosis is periportal predominant; this | ||
is not typical for NASH or ASH. Clinical correlation is | is not typical for NASH or ASH. Clinical correlation and review of medications | ||
is suggested. | |||
</pre> | </pre> | ||
edits